Register entryRepackager / relabeller

HAWAII REPACK INC

Data as of · How to read this entry

Registered sites
1
Active NDC listings
91
Labeller names
2
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

Relabelling1Repackaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
HAWAII REPACK, INC.Registrant: HAWAII REPACK INC677 Ala Moana Blvd Ste 700, Honolulu, Hawaii (HI) 96813, United States (USA)Relabelling, Repackaging3037867829137163862
Catalogue

Drug listings by form and route

91

91 active NDC listings: 81 human prescription drug, 6 bulk ingredient, 2 drug for further processing, 2 human otc drug. By marketing category: ANDA 80, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 6, DRUG FOR FURTHER PROCESSING 2, OTC MONOGRAPH DRUG 2, NDA AUTHORIZED GENERIC 1.

Dosage formNDCs
capsule22
tablet19
tablet, film coated12
capsule, delayed release7
kit6
powder, for suspension6
tablet, delayed release4
capsule, delayed release pellets3
powder2
tablet, orally disintegrating2
aerosol, metered1
gel1
ointment1
patch1
solution1
RouteNDCs
oral77
topical3
cutaneous1
ophthalmic1
respiratory (inhalation)1
Labeller name on the listingNDCs
hawaii repack, inc.85
hawaii repack, inc6
Catalogue

Marketed products

91
BrandGeneric nameForm / routeNDC
Albuterol SulfateAlbuterol Sulfateaerosol, metered, respiratory (inhalation)85534-0039ANDA
-Amitryptline Hydrochloridekit85534-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Amitryptline Hydrochloridekit85534-0002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
AmoxicillinAmoxicillincapsule, oral85534-0040ANDA
AmoxicillinAmoxicillinpowder, for suspension, oral85534-0070ANDA
AmoxicillinAmoxicillinpowder, for suspension, oral85534-0071ANDA
AmoxicillinAmoxicillinpowder, for suspension, oral85534-0072ANDA
AmoxicillinAmoxicillinpowder, for suspension, oral85534-0073ANDA
Amoxicillin and Clavulanate PotassiumAmoxicillin and Clavulanate Potassiumpowder, for suspension, oral85534-0041ANDA
Amoxicillin and Clavulanate PotassiumAmoxicillin and Clavulanate Potassiumpowder, for suspension, oral85534-0080ANDA
Aspirin 81 mgAspirintablet, coated, oral85534-0042OTC MONOGRAPH DRUG
BACLOFENBACLOFENtablet, oral85534-0004ANDA
Bupropion HydrochlorideBupropion Hydrochloridetablet, extended release, oral85534-0006ANDA
Butalbital, Acetaminophen, CaffeineButalbital, Acetaminophen, and Caffeinetablet, oral85534-0046ANDA
CYCLOBENZAPRINE HYDROCHLORIDEcyclobenzaprine hydrochloridetablet, film coated, oral85534-0005ANDA
CYCLOBENZAPRINE HYDROCHLORIDEcyclobenzaprine hydrochloridetablet, film coated, oral85534-0085ANDA
CYCLOBENZAPRINE HYDROCHLORIDEcyclobenzaprine hydrochloridetablet, film coated, oral85534-0086ANDA
CelecoxibCelecoxibcapsule, oral85534-0015ANDA
CelecoxibCelecoxibcapsule, oral85534-0066ANDA
CelecoxibCelecoxibcapsule, oral85534-0067ANDA
CelecoxibCelecoxibcapsule, oral85534-0068ANDA
CephalexinCephalexincapsule, oral85534-0076ANDA
CephalexinCephalexincapsule, oral85534-0077ANDA
CephalexinCephalexincapsule, oral85534-0078ANDA
CephalexinCephalexincapsule, oral85534-0079ANDA
CiprofloxacinCiprofloxacin Hydrochloridetablet, film coated, oral85534-0047ANDA
CiprofloxacinCiprofloxacin Hydrochloridetablet, film coated, oral85534-0069ANDA
CiprofloxacinCiprofloxacin Hydrochloridetablet, film coated, oral85534-0081ANDA
Clindamycin hydrochlorideClindamycin hydrochloridecapsule, oral85534-0087ANDA
Clindamycin hydrochlorideClindamycin hydrochloridecapsule, oral85534-0088ANDA
-Cyclobenzaprine Hydrochloridekit85534-0100BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Cyclobenzaprine Hydrochloridekit85534-0126BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
DICLOFENAC SODIUMdiclofenac sodiumgel, topical85534-0089ANDA
Diclofenac EpolamineDiclofenac Epolaminesystem, topical85534-0034NDA AUTHORIZED GENERIC
-Diclofenac Sodiumpowder85534-0099DRUG FOR FURTHER PROCESSING
-Diclofenac Sodiumpowder85534-0127DRUG FOR FURTHER PROCESSING
DuloxetineDuloxetinecapsule, delayed release, oral85534-0016ANDA
DuloxetineDuloxetinecapsule, delayed release pellets, oral85534-0017ANDA
DuloxetineDuloxetinecapsule, delayed release, oral85534-0018ANDA
DuloxetineDuloxetinecapsule, delayed release pellets, oral85534-0050ANDA
DuloxetineDuloxetinecapsule, delayed release pellets, oral85534-0051ANDA
DuloxetineDuloxetinecapsule, delayed release, oral85534-0052ANDA
DuloxetineDuloxetinecapsule, delayed release, oral85534-0053ANDA
FAMOTIDINEFAMOTIDINEtablet, film coated, oral85534-0091ANDA
FAMOTIDINEFAMOTIDINEtablet, film coated, oral85534-0092ANDA
FLUCONAZOLEFLUCONAZOLEtablet, oral85534-0049ANDA
GabapentinGabapentincapsule, oral85534-0003ANDA
GabapentinGabapentincapsule, oral85534-0007ANDA
GabapentinGabapentincapsule, oral85534-0008ANDA
GabapentinGabapentintablet, oral85534-0009ANDA
GabapentinGabapentintablet, oral85534-0010ANDA
GabapentinGabapentincapsule, oral85534-0054ANDA
GabapentinGabapentincapsule, oral85534-0055ANDA
GabapentinGabapentincapsule, oral85534-0056ANDA
IbuprofenIbuprofentablet, oral85534-0011ANDA
IbuprofenIbuprofentablet, oral85534-0012ANDA
IbuprofenIbuprofentablet, oral85534-0013ANDA
LevofloxacinLevofloxacintablet, film coated, oral85534-0096ANDA
LevofloxacinLevofloxacintablet, film coated, oral85534-0097ANDA
LevofloxacinLevofloxacintablet, film coated, oral85534-0098ANDA
-Lidocaine Hydrochloridekit85534-0101BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Lidocaine Hydrochloridekit85534-0128BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
METHYLPREDNISOLONEMETHYLPREDNISOLONEtablet, oral85534-0035ANDA
Methocarbamolmethocarbamoltablet, oral85534-0021ANDA
Methocarbamolmethocarbamoltablet, oral85534-0022ANDA
Methocarbamolmethocarbamoltablet, oral85534-0057ANDA
NaproxenNaproxentablet, oral85534-0023ANDA
NaproxenNaproxentablet, oral85534-0024ANDA
NaproxenNaproxentablet, oral85534-0058ANDA
Olu Pain Managementlidocaine and camphorpatch, cutaneous85534-0102OTC MONOGRAPH DRUG
OmeprazoleOmeprazolecapsule, delayed release, oral85534-0036ANDA
OmeprazoleOmeprazolecapsule, delayed release, oral85534-0037ANDA
OmeprazoleOmeprazolecapsule, delayed release, oral85534-0064ANDA
OndansetronOndansetrontablet, orally disintegrating, oral85534-0025ANDA
OndansetronOndansetrontablet, orally disintegrating, oral85534-0063ANDA
PANTOPRAZOLE SODIUMPANTOPRAZOLEtablet, delayed release, oral85534-0028ANDA
PANTOPRAZOLE SODIUMPANTOPRAZOLEtablet, delayed release, oral85534-0062ANDA
Pantoprazole SodiumPantoprazole Sodiumtablet, delayed release, oral85534-0027ANDA
Pantoprazole SodiumPantoprazole Sodiumtablet, delayed release, oral85534-0061ANDA
ParoxetineParoxetinetablet, film coated, oral85534-0026ANDA
TizanidineTizanidinetablet, oral85534-0029ANDA
TizanidineTizanidinetablet, oral85534-0030ANDA
celecoxibcelecoxibcapsule, oral85534-0014ANDA
celecoxibcelecoxibcapsule, oral85534-0059ANDA
celecoxibcelecoxibcapsule, oral85534-0060ANDA
celecoxibcelecoxibcapsule, oral85534-0065ANDA
ciprofloxacinCiprofloxacinsolution, ophthalmic85534-0075ANDA
doxycycline hyclatedoxycycline hyclatecapsule, oral85534-0048ANDA
meloxicammeloxicamtablet, oral85534-0019ANDA
meloxicammeloxicamtablet, oral85534-0020ANDA
mupirocinMupirocinointment, topical85534-0038ANDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is HAWAII REPACK INC FDA approved?
HAWAII REPACK INC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are HAWAII REPACK INC's registered sites?
The FDA register lists Honolulu, HI. Registered operations: relabelling, repackaging.
What drugs does HAWAII REPACK INC make?
91 products are listed under HAWAII REPACK INC in the openFDA NDC Directory, most often as capsule; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.